NCT06238765View on ClinicalTrials.gov

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 2, 2023

Primary Completion Date

December 31, 2099

Study Completion Date

December 31, 2099

Conditions
Atopic Dermatitis
Trial Locations (1)

02451

RECRUITING

CorEvitas, LLC, Waltham

Sponsors

Lead Sponsor

CorEvitas
All Listed Sponsors
lead

CorEvitas

NETWORK

NCT06238765 - CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry | Biotech Hunter | Biotech Hunter